Mental status change, myoclonus, electrocardiographic changes, and acute respiratory distress syndrome induced by quetiapine overdose

Pharmacotherapy

Volumn 26, Issue 4, 2006, Pages 578-582

  Strachan, Paul M ^a   Benoff, Brian A ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Acute respiratory distress syndrome; ARDS; Electrocardiographic changes; Myoclonus; Quetiapine overdose

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; QUETIAPINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; BIPOLAR DISORDER; CASE REPORT; DRUG OVERDOSE; ELECTROCARDIOGRAM; HUMAN; HYPOXIA; INTENSIVE CARE UNIT; INTUBATION; LUNG INFILTRATE; MALE; MENTAL HEALTH; MYOCLONUS; QT PROLONGATION; RESPIRATORY FAILURE; THORAX RADIOGRAPHY;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; ELECTROCARDIOGRAPHY; HUMANS; MALE; MENTAL HEALTH; MYOCLONUS; OVERDOSE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33645671633     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.4.578     Document Type: Article

References (17)

1. Mosby Drug Consult. Home page. Available from http://www. mosbydrugconsult.com/DrugConsult/Top_200/Dru gs/e3359.html. Accessed February 7, 2005.
2. Borisonm RL, Arvantis LA, Miller BG. ICI 204, 636, an atypical antipsychotic: efficacy and safety in a multicenter placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL study group. J Clin Psychopharmacol 1996;16:158-69.
3. Gajwani P, Pozuelo L, Tesar G. QT interval prolongation associated with quetiapine (Seroquel) overdose. Psychosomatics 2000;41:63-5.
4. Beelen A, Yeo K, Lewis L. Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exper Toxicol 2001;20:215-19.
5. Vivek S. No QT interval prolongation associated with quetiapine overdose [letter]. Am J Emerg Med 2004;22:330.
6. Balit C, Isbister G, Hackett L, Whyte I. Quetiapine poisoning: a case series. Ann Emerg Med 2003;42:751-8.
7. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000;355:1048-52.
8. Edwards JG, Goldie A, Papayanni-Papasthatis S. Effect of paroxetine on the electrocardiogram. Psychopharmacology (Berlin) 1989;97:96-8.
9. Sala M, Vicentini A, Brambilla P, et al. QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry 2005;4:1-6.
10. Centorrino F, Price B, Tuttle M, et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 2002;159:109-15.
11. Amann BL, Pogarell O, Mergl R, et al. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 2003;18:641-6.
12. Dogu O, Sevim S, Kaleagasi H. Seizures associated with quetiapine treatment. Ann Pharmacother 2003;37:1224-7.
13. Hedges DW, Jeppson KG. New-onset seizures associated with quetiapine and olanzapine. Ann Pharmacother 2002;36:437-9.
14. Precourt A, Dunewicz M, Gregoire G, Williamson DR. Multiple complications and withdrawal syndrome associated with quetiapine/venlafaxine intoxication. Ann Pharmacother 2005;39:153-6.
15. Harmon TJ, Benitez JG, Krenzelok EP, Cortes-Belen E. Loss of consciousness from acute quetiapine overdose. J Toxicol Clin Toxicol 1998;36:599-602.
16. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;ii:319-23.
17. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.